Abstract
Introduction

62
The gram-negative bacterium Pseudomonas aeruginosa uses a complex type III 63 secretion system (T3SS) to inject effector proteins into host cells [1, 2] . The T3SS is a major 64 virulence determinant that manipulates eukaryotic host cell responses that is present in a broad 65 range of pathogens. It is a specialized needle-like structure that delivers effector toxins directly 66 from the bacterium into the host cytosol in a highly regulated manner [3] . This system is 67 activated on contact with eukaryotic cell membranes, interferes with signal transduction, and 68 causes cell death or alterations in host immune responses [4] . The T3SS in P. aeruginosa has 69 been linked to severe disease and poor clinical outcomes in animal and human studies [4, 5] .
70
The features of this interesting secretion system have important implications for the 
MUC1, MUC2, MUC3A, MUC3B, MUC4, MUC5AC, MUC5B, MUC6, MUC7, MUC8, MUC9,
85
MUC12, MUC13, MUC15, MUC16, MUC17, MUC19, MUC20, MUC21
, and MUC22) [13] . 86 However, these mucins cannot maintain homeostasis in intrabronchial respiratory epithelial 87 cells of patients with weak immunity, and when overexpressed, cause mucous membrane 88 damage due to excessive secretion of mucus, and need to be blocked. However, the underlying 89 mechanisms have been clearly clarified for only a few mucins to date. Muc7, Muc13, Muc15, 90 and Muc19 have been implicated in bronchial inflammation among mucin targets, but the 91 mechanism of the mechanism has not been studied to date. Especially in immunocompromised 92 patients and children infected with the opportunistic pathogen P. aeruginosa, the risk of 93 secondary infection is high and leads to not only asthma and airway hypersensitivity as well as 94 deterioration of existing disease, but also mucus accumulation, which can result in terrible 95 death due to difficulty of breathing by chronic obstructive pulmonary disease [14, 15] . However, 96 the mechanism underlying this condition is yet to be clarified.
97
NF-κB is also a high expression level transcription factor involved in many 98 inflammation`s formation and development [16] . Moreover, SP1/NF-κB pathway has been 99 reported connected to cell migration, invasion and EMT (epithelial to mesenchymal transition) 100 recently [17, 18] . Furthermore, SP1 and NF-κB (p65) were found significantly upregulated in 
Materials and Methods
111
Bacterial strains
112
All strains and plasmids used in this study are listed in Supporting information S1
113 Table. Chromosomal mutants were all derived from the same parental PAK strain, as indicated 114 in S1 Table, and were generated by allelic exchange (for details, see the Supporting information 115 S1 Text). PAK strains vary widely in their expression of virulence genes. The strain used in 116 this study strongly expresses the T3SS genes. Regions flanking the appropriate mutation were 117 amplified using chromosomal DNA as a template (unless specified otherwise), joined by
118
"splicing by overlap extension PCR," and cloned into the appropriate plasmid using the 119 indicated restriction enzymes. PAK-ΔST is a P. aeruginosa clinical isolate that naturally carries 120 the ExoY gene, but lacks the genes for ExoS and ExoT. We reported that the pUCP18-
121
PAKexoS (S) and pUCP18-PAKexoT (T) mutant strains are secretion competent and export 122 the expected effector proteins [19] . Antibiotics were used when necessary at the following 123 concentrations: for plasmids in Escherichia coli, 50 μg/mL ampicillin, 15 μg/mL gentamicin,
124
and 25 μg/mL kanamycin; for P. aeruginosa, 500 μg/mL carbenicillin, 100 μg/mL gentamicin,
125
and 100 μg/mL tetracycline. 
qRT-PCR analysis
142
Total RNA was extracted using TRIzol ® reagent (Invitrogen) following the 143 manufacturer's protocol and was used to synthesize cDNA using the AMPIGENE ® cDNA 144 Synthesis Kit (Enzo Life Sciences, NY, USA). PCRs were conducted using SYBR Green PCR
145
Master Mix (KAPA Biosystems, Woburn, MA, USA) and the primers listed in S2 Table. 146
Reactions were run in a CFX96 real-time PCR system (Bio-Rad, Hercules, CA, USA) using 
Immunoblot analysis
152
Cells were lysed with 20 mM Tris-HCl (pH 7.4), 50 mM NaCl, 50 mM sodium 153 phosphate, 30 mM NaF, 5 μM zinc chloride, 2 mM iodoacetic acid, and 1% Triton X-100 for USA) according to the manufacturer's protocol. Twenty hours after transfection, the cells were stimulated with PAK for 2 h, harvested, and assessed for luciferase activity using the ONE-
180
Glo TM luciferase reporter assay system (Promega) according to the manufacturer's instructions. Scientific, Inc.). After 6 h, the medium was changed with RPMI1640 containing 10% FBS.
223
Cells were harvested at 48 h after transfection for RT-qPCR or at 72 h for western blot analysis.
224
Three different IKKα/IKKβ-specific siRNAs were screened, and the most efficient one was (Fig 1I) level. The mRNA expression of all 4 mucins tended to decrease 244 after 12 h, while at the protein level, expression decreased after 4 h (Fig 1E-H, J) . Muc15, and Muc19 mRNA expression induced by PAK (Fig 2A-D) . The effect of PAK on (Fig 2E) . induce their expression as compared to non-infected control cells (Fig 3A-D) . Similar findings 280 were obtained for mucin protein expression (Fig 3A-D) . AKT and SP1 phosphorylation was 281 less strongly induced by exsA::Ω than by wild-type PAC as indicated by western blotting (Fig   282   3E ). SP1 and NF-κB transcription factor activities were significantly induced by wild-type 15 283 PAC but not by exsA::Ω as indicated by luciferase assays (Fig 3F, H) . Similar to AKT and SP1 284 phosphorylation, p65 and IκBa phosphorylation was less strongly induced by exsA::Ω than by 285 wild-type PAC as indicated by western blotting (Fig 3I) . IHC confirmed the findings for SP1 286 and p65 (Fig 3G, J) . There are multiple reports that PAK affects NF-κB signaling, but there 287 was no report that PAK phosphorylated p65, IκBa and SP1 to affect Muc7, Muc13, Muc15, ExoS and ExoT, respectively, and TNF-α was restored to about 60% and 55% of the PAK- 
Muc19 expression via NF-κB p65 and AKT phosphorylation in A549 cells
314
Next, we investigated whether ExoS and ExoT are related to known SP1/AKT and 315 NF-κB signals, which are involved in pneumonia and lung diseases, using the mutant strains.
316
The results showed that S and T induced the activation of the SP1/AKT pathway and AKT and 317 p65 phosphorylation in A549 cells nearly to the level the wild-type PAK strain did, while ΔST 318 completely the ability to do so (Fig 5A-D) . In particular, it was confirmed that increased SP1, 319 known as a transcription factor for AKT and increases the phosphorylation of IκBα (Fig. 5A- 
D). These results indicated that ExoS and ExoT are important virulence factors of P.
321 aeruginosa and are very important for the induction of the inflammatory response in host cells. When we tested the ΔST, S, and T strains, Muc7, Muc13, Muc15, and Muc19 mRNA 336 and protein expression were significantly increased by S and T, but not ΔST, as indicated by 337 qPCR and western blotting (Fig 6A-E) . Similar findings were achieved for proinflammatory 
Roles of ExoS and ExoT in AKT activation in mice
342
Proinflammatory cytokine production was increased through the T3SS of PAK, and showed a significant increase in SP1 translocation, which was detectable as of 30 min and was 348 sustained for 1 h (Fig 7A) . and Muc19 were suppressed by 40-60% (Fig 8A-D) . 
404
The results generated in the current study increase our understanding of the 
473
At 24 h after transfection, A549 cells were treated with the strains at MOI = 20 for 1 h, and 474 then, luciferase activity was measured. The data were normalized to β-galactosidase activity.
475
All data are representative of 3 independent experiments. Luciferase activities were measured Mock, PAKΔSTmt-pUCP18; S, PAKΔSTmt-pUCP18PAKexoS; T, PAKΔSTmt-487 pUCP18PAKexoT (MOI 2.5 × 10 6 ) #Significantly different from the non-infected control cells, 488 *P < 0.05, **P < 0.01, ***P < 0.001, significantly different from PAK-only-infected cells. 
